Research Topic · Peer-Reviewed

Small Cell Lung Cancer

Small cell lung cancer (SCLC) is an aggressive, fast-growing form of lung cancer that arises from neuroendocrine cells of the lung and is distinguished by small, densely packed tumor cells that tend to spread early and widely. It accounts for a minority of lung cancers but is among the most rapidly progressing, and …

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 52× across the literature 🗓 Reviewed July 2026

Overview

Small cell lung cancer (SCLC) is an aggressive, fast-growing form of lung cancer that arises from neuroendocrine cells of the lung and is distinguished by small, densely packed tumor cells that tend to spread early and widely. It accounts for a minority of lung cancers but is among the most rapidly progressing, and is strongly associated with tobacco smoking. Because SCLC often disseminates before it is detected, it generally carries a poorer prognosis than non-small cell lung cancer, and treatment typically centers on chemotherapy and radiation rather than surgery, with early detection critical to outcomes. Within the broader epidemiology of lung cancer, related areas of study include risk factors and prevention, screening and diagnostic methods, surgical and immunotherapeutic approaches, and the tumor biology that governs growth and metastasis. Research relevant to this journal addresses novel methods for the prevention, prognosis, diagnosis, imaging, screening, treatment, and management of lung cancer, trends in surgical resection and the impact of immunotherapy on operative practice, the role of agents such as heparin in lung cancer, biomarker development through advanced disease-modeling platforms, and immune-checkpoint and complementary treatment strategies, reflecting the wide-ranging effort to understand and address the burden of lung cancer, including its most aggressive small cell form.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

The Role of Heparin in Lung Cancer

Abu Arab WalidCorresponding author
Service de Chirurgie thoracique, Université de Sherbrooke, Québec, Canada
Exact topic Neoplasms Cited by 7 doi:10.14302/issn.2639-1716.jn-17-1499
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 52 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Small Cell Lung Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Lung Cancer Epidemiology.

Journal editorial board
Krzysztof Roszkowski · Poland Peter Lee · United Kingdom Jonathan Riess · United States

This page summarises published research for orientation; it is not medical or professional advice.